// App-Quantinova.ai

: CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO

Researchers

Presenter

  • Eric Xueyu Chen

Principal Investigators

  • Severa Bunda

  • Alireza Mansouri

  • Kenneth Aldape

  • Gelareh Zadeh

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • MacFeeters-Hamilton Center for Neuro-Oncology Research, Toronto, ON, Canada

  • MacFeeters-Hamilton Center for Neuro-Oncology Research, Toronto, ON, CanadaLabortory of Pathology, NIH, Bethesda, MD, USA

  • MacFeeters-Hamilton Center for Neuro-Oncology Research, Toronto, ON, CanadaToronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Proliferation marker protein Ki-67

  • Hexokinase 1

Drug/Treatment

  • Posaconazole

  • Ketoconazole

  • azoles

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved